Pharma Deals Review, Vol 2003, No 33 (2003)

Font Size:  Small  Medium  Large

Roche to Bid US$1.2 B for Diabetes Firm, Disetronic

Business Review Editor

Abstract


Roche has made a cash and share bid to acquire Disetronic. Roche offers CHF670 in cash and two Roche non-voting shares for each of the 1.9 million shares in Disetronic.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.